Skip to main content
. 2014 Sep 26;9(9):e107213. doi: 10.1371/journal.pone.0107213

Figure 1. DM199 treatment reduces type 1 diabetes incidence.

Figure 1

The fraction of non-diabetic NOD mice remaining over an 18-week treatment period (Cohort 1) is shown. Animals with non-fasting blood glucose >250 mg/dL for two consecutive days were considered diabetic and were removed from the study. None of the mice in any treatment groups developed diabetes in the first 6 weeks of the study. Groups of NOD mice were injected with vehicle or DM199 i.p. as indicated in the legend; n, initial number in each group. *P<0.05 in comparison to control using a log-rank test.